IL2RA and diabetes mellitus: Enhanced suppression + reversal of diabetogenic T cell-induced diabetes in NOD.RAG-/- or NOD CD28-/- mice (only slight delay of disease with 4-fold higher numbers of polyclonal CD4+ CD25+ NOD Treg cells)